SST and Parkinson disease: Recent evidence suggest that somatostatin contributes to the pathology of anxiety and depression (Fuchs et al., 2016; Fee et al., 2017), levels of this GABAergic marker being low in cerebrospinal fluid and induced pluripotent cells of PD patients (Dupont et al., 1982; Iwasawa et al., 2019).